PHARMACOKINETIC EVALUATION OF BETA-LACTAM ANTIBIOTICS

[1] GIBALDI M, 1982, PHARMACOKINETICS

[2] KUNIN CM, 1973, ANN NY ACAD SCI, V26, P214

[3] PHARMACOKINETIC CONSIDERATIONS FOR THE SETTING OF INVITRO MODELS [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 : 85 - 97

[4] EFFECT OF PROTEIN-BINDING ON ANTIBIOTIC-ACTIVITY INVIVO [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 (03) : 233 - 238

[5] THE INFLUENCE OF PROTEIN-BINDING UPON TISSUE-FLUID LEVELS OF 6 BETA-LACTAM ANTIBIOTICS [J]. JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (01) : 77 - 82

[6] DISPOSITION OF CEFOTAXIME AND ITS DESACETYL METABOLITE IN MORBIDLY OBESE MALE AND FEMALE SUBJECTS [J]. THERAPEUTIC DRUG MONITORING, 1986, 8 (02) : 189 - 194

[1] GIBALDI M, 1982, PHARMACOKINETICS

[2] KUNIN CM, 1973, ANN NY ACAD SCI, V26, P214

[3] PHARMACOKINETIC CONSIDERATIONS FOR THE SETTING OF INVITRO MODELS [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 : 85 - 97

[4] EFFECT OF PROTEIN-BINDING ON ANTIBIOTIC-ACTIVITY INVIVO [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 (03) : 233 - 238

[5] THE INFLUENCE OF PROTEIN-BINDING UPON TISSUE-FLUID LEVELS OF 6 BETA-LACTAM ANTIBIOTICS [J]. JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (01) : 77 - 82

[6] DISPOSITION OF CEFOTAXIME AND ITS DESACETYL METABOLITE IN MORBIDLY OBESE MALE AND FEMALE SUBJECTS [J]. THERAPEUTIC DRUG MONITORING, 1986, 8 (02) : 189 - 194